194 related articles for article (PubMed ID: 33868594)
1. Subtypes identification on heart failure with preserved ejection fraction via network enhancement fusion using multi-omics data.
Wu Y; Wang H; Li Z; Cheng J; Fang R; Cao H; Cui Y
Comput Struct Biotechnol J; 2021; 19():1567-1578. PubMed ID: 33868594
[TBL] [Abstract][Full Text] [Related]
2. Multi-omics data integration for subtype identification of Chinese lower-grade gliomas: A joint similarity network fusion approach.
Li L; Wei Y; Shi G; Yang H; Li Z; Fang R; Cao H; Cui Y
Comput Struct Biotechnol J; 2022; 20():3482-3492. PubMed ID: 35860412
[TBL] [Abstract][Full Text] [Related]
3. Morphometric, Hemodynamic, and Multi-Omics Analyses in Heart Failure Rats with Preserved Ejection Fraction.
Zhang W; Zhang H; Yao W; Li L; Niu P; Huo Y; Tan W
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397533
[TBL] [Abstract][Full Text] [Related]
4. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
[TBL] [Abstract][Full Text] [Related]
5. Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs.
Chen YT; Wong LL; Liew OW; Richards AM
Cells; 2019 Dec; 8(12):. PubMed ID: 31888288
[TBL] [Abstract][Full Text] [Related]
6. Multi-omics data integration for hepatocellular carcinoma subtyping with multi-kernel learning.
Wang J; Miao Y; Li L; Wu Y; Ren Y; Cui Y; Cao H
Front Genet; 2022; 13():962870. PubMed ID: 36147508
[TBL] [Abstract][Full Text] [Related]
7. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.
Kao DP; Lewsey JD; Anand IS; Massie BM; Zile MR; Carson PE; McKelvie RS; Komajda M; McMurray JJ; Lindenfeld J
Eur J Heart Fail; 2015 Sep; 17(9):925-35. PubMed ID: 26250359
[TBL] [Abstract][Full Text] [Related]
8. Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction.
Tromp J; Westenbrink BD; Ouwerkerk W; van Veldhuisen DJ; Samani NJ; Ponikowski P; Metra M; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Lang CC; Ng LL; Zannad F; Zwinderman AH; Hillege HL; van der Meer P; Voors AA
J Am Coll Cardiol; 2018 Sep; 72(10):1081-1090. PubMed ID: 30165978
[TBL] [Abstract][Full Text] [Related]
9. How do patients with heart failure with preserved ejection fraction die?
Chan MM; Lam CS
Eur J Heart Fail; 2013 Jun; 15(6):604-13. PubMed ID: 23610137
[TBL] [Abstract][Full Text] [Related]
10. Effective blood hemoglobin level to predict prognosis in heart failure with preserved left ventricular ejection fraction: results of the Japanese heart failure syndrome with preserved ejection fraction registry.
Okuno K; Naito Y; Asakura M; Sugahara M; Ando T; Yasumura S; Nagai T; Saito Y; Yoshikawa T; Masuyama T; Anzai T
Heart Vessels; 2019 Jul; 34(7):1168-1177. PubMed ID: 30675647
[TBL] [Abstract][Full Text] [Related]
11. Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure).
Stienen S; Ferreira JP; Kobayashi M; Preud'homme G; Dobre D; Machu JL; Duarte K; Bresso E; Devignes MD; López N; Girerd N; Aakhus S; Ambrosio G; Brunner-La Rocca HP; Fontes-Carvalho R; Fraser AG; van Heerebeek L; Heymans S; de Keulenaer G; Marino P; McDonald K; Mebazaa A; Papp Z; Raddino R; Tschöpe C; Paulus WJ; Zannad F; Rossignol P
Biomarkers; 2020 Mar; 25(2):201-211. PubMed ID: 32063068
[No Abstract] [Full Text] [Related]
12. Current Management and Future Directions of Heart Failure With Preserved Ejection Fraction: a Contemporary Review.
Krittanawong C; Kukin ML
Curr Treat Options Cardiovasc Med; 2018 Mar; 20(4):28. PubMed ID: 29557071
[TBL] [Abstract][Full Text] [Related]
13. Using association signal annotations to boost similarity network fusion.
Ruan P; Wang Y; Shen R; Wang S
Bioinformatics; 2019 Oct; 35(19):3718-3726. PubMed ID: 30863842
[TBL] [Abstract][Full Text] [Related]
14. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
Brouwers FP; de Boer RA; van der Harst P; Voors AA; Gansevoort RT; Bakker SJ; Hillege HL; van Veldhuisen DJ; van Gilst WH
Eur Heart J; 2013 May; 34(19):1424-31. PubMed ID: 23470495
[TBL] [Abstract][Full Text] [Related]
15. Risk Prediction in Patients With Heart Failure With Preserved Ejection Fraction Using Gene Expression Data and Machine Learning.
Zhou L; Guo Z; Wang B; Wu Y; Li Z; Yao H; Fang R; Yang H; Cao H; Cui Y
Front Genet; 2021; 12():652315. PubMed ID: 33828587
[TBL] [Abstract][Full Text] [Related]
16. Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization.
Nikolova AP; Hitzeman TC; Baum R; Caldaruse AM; Agvanian S; Xie Y; Geft DR; Chang DH; Moriguchi JD; Hage A; Azarbal B; Czer LS; Kittleson MM; Patel JK; Wu AHB; Kobashigawa JA; Hamilton M; Hong T; Shaw RM
JAMA Cardiol; 2018 Dec; 3(12):1206-1210. PubMed ID: 30383171
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Heart Failure with Preserved Ejection Fraction.
Ilieșiu AM; Hodorogea AS
Adv Exp Med Biol; 2018; 1067():67-87. PubMed ID: 29498023
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
Heart; 2018 Mar; 104(6):525-532. PubMed ID: 28982721
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
[TBL] [Abstract][Full Text] [Related]
20. Sympathetic activation and outcomes in chronic heart failure: Does the neurohormonal hypothesis apply to mid-range and preserved ejection fraction patients?
Jimenez-Marrero S; Moliner P; Rodríguez-Costoya I; Enjuanes C; Alcoberro L; Yun S; Gonzalez-Costello J; Garay A; Tajes M; Calero E; Hidalgo E; Guerrero C; García-Romero E; Díez-López C; Cainzos-Achirica M; Comin-Colet J
Eur J Intern Med; 2020 Nov; 81():60-66. PubMed ID: 32718877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
